Aarey Drugs & Pharmaceuticals rose 2.53% to Rs 107.25 at 13:19 IST on BSE after the company said it received first commercial export order from Germany.
The announcement was made during trading hours today, 9 May 2017.Meanwhile, the S&P BSE Sensex was up 71.13 points, or 0.24% to 29,997.28.
On the BSE, 1.50 lakh shares were traded in the counter so far, compared with average daily volumes of 1.41 lakh shares in the past one quarter. The stock had hit a high of Rs 108 and a low of Rs 105 so far during the day. The stock hit a record high of Rs 109.80 on 28 April 2017. The stock hit a 52-week low of Rs 36 on 10 May 2016.
The stock had underperformed the market over the past one month till 8 May 2017, rising 0.67% compared with 0.74% rise in the Sensex. The scrip had, however, outperformed the market in past one quarter, rising 22.77% as against Sensex's 5.61% rise.
The small-cap company has equity capital of Rs 18.08 crore. Face value per share is Rs 10.
Aarey Drugs & Pharmaceuticals said it received first commercial export order for 20 metric tons of Thiobromine from Germany. The order will be executed by 30 June 2017.
More From This Section
Net profit of Aarey Drugs & Pharmaceuticals rose 775% to Rs 1.75 crore on 51.60% rise in net sales to Rs 96.01 crore in Q3 December 2016 Q3 December 2015.
Aarey Drugs & Pharmaceuticals is one of the rising manufacturer representatives and suppliers of pharmaceutical raw materials, chemicals, pharmaceuticals ingredients, APIs drugs, food colours and flavours.
Powered by Capital Market - Live News